{
  "ptid_time": "094_S_1417_2008-08-13",
  "img_path": "/data/qiuhui/data/adni/images/094_S_1417/2008-08-13/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 37,457 mm³, 24.8% above the reference mean. With a Z-score of 0.59 (72.2th percentile), this represents normal volume ; hippocampal volume measures 5,524 mm³, 31.2% below the reference mean. With a Z-score of -3.12 (0.1th percentile), this represents profound atrophy; whole brain volume measures 1,100,830 mm³, 3.0% below the reference mean. With a Z-score of -0.42 (33.7th percentile), this represents normal volume ; entorhinal cortex volume measures 2,525 mm³, 40.8% below the reference mean. With a Z-score of -2.82 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 16,406 mm³, 17.6% below the reference mean. With a Z-score of -1.46 (7.2th percentile), this represents mild atrophy; middle temporal gyrus volume measures 19,940 mm³, 11.0% below the reference mean. With a Z-score of -0.91 (18.2th percentile), this represents normal volume . ",
  "text_data": "Age is 64.1 years. Gender is Male. Education: 12 years. Handedness: Unknown. Race: Unknown. MMSE: 28.0. Logical Memory: 6.0. APOEε4 alleles: 0.0. Biomarker levels: Pittsburgh compound B: 1.32 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound atrophy in the hippocampus (-3.12 Z-score) and significant atrophy in the entorhinal cortex (-2.82 Z-score), both key regions in Alzheimer's pathology. Despite normal MMSE (28/30) and no APOE4 risk allele, the severe medial temporal lobe atrophy suggests neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype due to hippocampal involvement).  \n\n**Confidence:** **Medium** (high confidence in neurodegeneration, but clinical correlation needed due to normal MMSE and lack of reported symptoms).  \n\n*Note:* If cognitive symptoms (e.g., memory complaints) are present, this would strongly support MCI. If asymptomatic, monitor closely as this may represent preclinical AD. Low whole-brain atrophy argues against advanced dementia.",
  "timestamp": "2025-07-26T10:24:27.457340"
}